Current proteomic analysis and post-translational modifications of biomarkers in human lung cancer materials

Chang Gung Medical Journal

Volumn 31, Issue 5, 2008, Pages 417-430

  Sinchaikul, Supachok ^a   Hongsachart, Piyorot ^a,b   Sriyam, Supawadee ^a,b   Tantipaiboonwong, Payungsak ^c   Phutrakul, Suree ^b   Chen, Shui Tein ^a,d,e  

^a GENOMICS RESEARCH CENTER   (Taiwan)

^b CHIANG MAI UNIVERSITY   (Thailand)

^c MAE FAH LUANG UNIVERSITY   (Thailand)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

Author keywords

Bioinformatics; Biomarkers; Human materials; Lung cancer; Post translational modification; Proteomics

Indexed keywords

ALPHA ENOLASE; APOLIPOPROTEIN A1; BIOLOGICAL MARKER; CALCIUM BINDING PROTEIN; CARBONATE DEHYDRATASE; CATALASE; CHAPERONE; CLUSTERIN; FICOLIN; FRUCTOSE BISPHOSPHATE ALDOLASE; GELSOLIN; GLUTATHIONE TRANSFERASE; GROWTH FACTOR; HAPTOGLOBIN; IMMUNOGLOBULIN LAMBDA CHAIN; INORGANIC PYROPHOSPHATASE; LEUKOCYTE ELASTASE INHIBITOR; LUMICAN; PHOSPHOGLYCERATE MUTASE; PLASMA PROTEIN; PREALBUMIN; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SERUM AMYLOID P; TETRANECTIN; TRIOSEPHOSPHATE ISOMERASE; UBIQUITIN THIOLESTERASE; UNINDEXED DRUG; VISFATIN; VITRONECTIN;

ADENOCARCINOMA; ANION EXCHANGE CHROMATOGRAPHY; BETA CHAIN; BIOINFORMATICS; BREAST CANCER; BRONCHUS CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE REGULATION; CELL LINE; COLON CANCER; DOWN REGULATION; EARLY DIAGNOSIS; ELECTROSPRAY; ESOPHAGUS CANCER; GALLBLADDER CANCER; GLYCOSYLATION; HEAT SHOCK; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; LIQUID CHROMATOGRAPHY; LIVER CANCER; LUNG CANCER; LUNG SMALL CELL CANCER; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUTH CANCER; NASOPHARYNX CANCER; NONHODGKIN LYMPHOMA; OVARY CANCER; PANCREAS CANCER; PLASMA; PLEURA EFFUSION; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEOMICS; RADIOIMMUNOASSAY; RECTUM CANCER; REVIEW; SERUM; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; STOMACH CANCER; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TAIWAN; TISSUE; TRACHEA CANCER; TUMOR GROWTH; TWO DIMENSIONAL ELECTROPHORESIS; TWO DIMENSIONAL GEL ELECTROPHORESIS; URINE; UTERINE CERVIX CANCER; WESTERN BLOTTING;

BIOLOGICAL MARKERS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOMICS;

EID: 54349129401     PISSN: 02558270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
2. Hse PY, Statistics on Causes of Death, Health Statistics in Taiwan, 2006. Department of Health, Executive Yuan, Taiwan, R.O.C. 2006;www.doh.gov.tw.
3. Ko YC, Wang JL, Wu CC, Huang WT, Lin MC. Lung cancer at a medical center in southern Taiwan. Chang Gung Med J 2005;28:387-95.
4. Fujii K, Nakano T, Kanazawa M, Akimoto S, Hirano T, Kato H, Nishimura T. Clinical-scale high-throughput human plasma proteome analysis: lung adenocarcinoma. Proteomics 2005;5:1150-9.
5. Maciel CM, Junqueira M, Paschoal ME, Kawamura MT, Duarte RL, Carvalho Mda G, Domont GB. Differential proteomic serum pattern of low molecular weight proteins expressed by adenocarcinoma lung cancer patients. J Exp Ther Oncol 2005;5:31-8.
6. Yang SY, Xiao XY, Zhang WG, Zhang LJ, Zhang W, Zhou B, Chen G, He DC. Application of serum SELDI proteomic patterns in diagnosis of lung. BMC Cancer 2005;5:83.
7. Okano T, Kondo T, Kakisaka T, Fujii K, Yamada M, Kato H, Nishimura T, Gemma A, Kudoh S, Hirohashi S. Plasma proteomics of lung cancer by a linkage of multidimensional liquid chromatography and two-dimensional difference gel electrophoresis. Proteomics 2006;6;3938-48.
8. Liu L, Liu J, Dai S, Wang X, Wu S, Wang J, Huang L, Xiao X, He D. Reduced transthyretin expression in sera of lung cancer. Cancer Sci 2007;98:1617-24.
9. Chen G, Gharib TG, Huang CC, Thomas DG, Shedden KA, Taylor JM, Kardia SL, Misek DE, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, Beer DG. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. Clin Cancer Res 2002;8:2298-305.
10. Chen G, Gharib TG, Wang H, Huang CC, Kuick R, Thomas DG, Shedden KA, Misek DE, Taylor JM, Giordano TJ, Kardia SL, Iannettoni MD, Yee J, Hogg PJ, Orringer MB, Hanash SM, Beer DG. Protein profiles associated with survival in lung adenocarcinoma. Proc Natl Acad Sci USA 2003;100:13537-42.
11. Li C, Chen Z, Xiao Z, Wu X, Zhan X, Zhang X, Li M, Li J, Feng X, L S, Chen P, Xie JY. Comparative proteomics analysis of human lung squamous carcinoma. Biochem Biophys Res Commun 2003;309:253-60.
12. Li LS, Kin H, Rhee H, Kim SH, Shih DH, Chung KY, Park KS, Paik YK, Chang J, Kim H. Proteomic analysis distinguishes basaloid carcinoma as a distinct subtype of non-small cell lung carcinoma. Proteomics 2004;4:3394-400.
13. Li C, Xiao Z, Chen Z, Zhang X, Li JL, Wu X, Li X, Yi H, Li M, Zhu G, Liang S. Proteome analysis of human lung squamous carcinoma. Proteomics 2006;6:547-58.
14. Seiko M, Kondo T, Fujii K, Okano T, Yamada T, Matsuno Y, Gemma A, Kudoh S, Hirohashi S. Proteomic signatures for histological types of lung cancer. Proteomics 2005;5:2939-48.
15. Xiao T, Ying W, Li L, Hu Z, Ma Y, Jiao L, Ma J, Cai Y, Lin D, Guo S, Han N, Di X, Li M, Zhang D, Su K, Yuan J, Zheng H, Gao M, He J, Shi S, Li W, Xu N, Zhang H, Liu Y, Zhang K, Gao Y, Qian X, Cheng S. An approach to studying lung cancer-related proteins in human blood. Mol Cell Proteomics 2005;4:1480-6.
16. Tian T, Hao J, Xu A, Hao J, Luo C, Liu C, Huang L, Xiao X, He D. Determination of metastasis-associated proteins in non-small cell lung cancer by comparative proteomic analysis. Cancer Sci 2007;98:1265-74.
17. Tantipaiboonwong P, Sinchaikul S, Sriyam S, Phutrakul S, Chen ST. Different techniques for urinary protein analysis of normal and lung cancer patients. Proteomics 2005;5:1140-9.
18. Tyan YC, Wu HY, Su WC, Liao PC. Proteomic profiling of human pleural effusion using two-dimensional nano liquid chromatography tandem mass spectrometry. J Proteome Res 2005;4:1274-86.
19. Liu H, Yang C, Yang Q, Zhang W, Zhang Y. On-line combination of capillary isoelectric focusing and capillary non-gel electrophoresis using a hollow-fiber membrane interface: a novel two-dimensional separation system for proteins. J Chromatogr B Analyt Technol Biomed Life Sci 2005;817:119-26.
20. Zhu G, Yuan H, Zhao P, Zhang L, Liang Z, Zhang W, Zhang Y. Macroporous polyacrylamide-based monolithic column with immobilized pH gradient for protein analysis. Electrophoresis 2006;27:3578-83.
21. Zhu C, He X, Kraly JR, Jones MR, Whitmore CD, Gomez DG, Eggertson M, Quigley W, Boardman A, Dovichi N. Instrumentation for medium-throughput two-dimensional capillary electrophoresis with laser-induced fluorescence detection. Anal Chem 2007;79:765-8.
22. Xiao X, Liu D, Tang Y, Guo F, Xia L, Liu J, He D. Development of proteomic patterns for detecting lung cancer. Dis Markers 2003-2004;19:33-9.
23. Zhong L, Hidalgo GE Stromberg AJ, Khattar NH, Jett JR, Hirschowitz EA. Using protein microarray as a diagnostic assay for non-small cell lung cancer. Am J Respir Crit Care Med 2005;172:1308-14.
24. Bartling B, Hofmann HS, Boettger T, Hansen G, Burdach S, Silber RE, Simm A. Comparative application of antibody and gene array for expression profiling in human squamous cell lung carcinoma. Lung Cancer 2005;49:145-54.
25. Gao WM, Kuick R, Orchekowski RP, Misek DE, Qiu J, Greenberg AK, Rom WN, Brenner DE, Omenn GS, Haab BB, Hanash SM. Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis. BMC Cancer 2005;5:110.
26. Mann M, Jensen ON. Proteomic analysis of post-translational modifications. Nat Biotechnol 2003;21:255-61.
27. Krueger KE, Srivastava S. Posttranslational modifications: current implications for cancer detection, prevention, and therapeutics. Mol Cell Proteomics 2006;5:1799-810.
28. Hanash S, Brichory F, Beer D. A proteomic approach to the identification of lung cancer markers. Dis Markers 2001;17:295-300.
29. Satoh H, Ishikawa H, Kamma H, Yamashita YT, Takahashi H, Ohtsuka M, Hasegawa S. Serum sialyl lewis X-i antigen levels in non-small cell lung cancer: correlation with distant metastasis and survival. Clin Cancer Res 1997;3:495-9.
30. Otake Y, Fujimoto I, Tanaka F, Nakagawa T, Ikeda T, Menon KK, Hase S, Wada H, Ikenaka K. Isolation and characterization of an N-linked oligosaccharide that is significantly increased in sera from patients with non-small cell lung cancer. J Biochem 2001;129:537-42.
31. Laack E, Nikbakht H, Peters A, Kugler C, Jasiewicz Y, Edler L, Hossfeld DK, Schumacher U. Lectin histochemistry of resected adenocarcinoma of the lung: helix pomatia agglutinin binding is an independent prognostic factor. Am J Pathol 2002;160:1001-8.
32. Lopez-Ferrer A, Barranco C, de Bolos C. Differences in the O-glycosylation patterns between lung squamous cell carcinoma and adenocarcinoma. Am J Clin Pathol 2002;118:749-55.
33. Geng F, Shi BZ, Yuan YF, Wu XZ. The expression of core fucosylation E-cadherin in cancer cells and lung cancer patients: prognostic implications. Cell Res 2004;14:423-33.
34. Gokmen SS, Kazezoglu C, Tabakoglu E, Altray G, Gungor O, Ture M. Serum total sialic acid levels in lung cancer patients of different histological types with and no extrapulmonary metastases. Turk J Biochem 2004;29:262-7.
35. Kossowska B, Ferens-Sieczkowska M, Gancarz R, Passowicz-Muszynska E, Jankowska R. Fucosylation of serum glycoproteins in lung cancer patients. Clin Chem Lab Med 2005;43:361-9.
36. Ueda K, Katagiri T, Shimada T, Irie S, Sato TA, Nakamura Y, Daigo Y. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer. J Proteome Res 2007;6:3475-83.
37. Gharib TG, Chen G, Wang H, Huang CC, Prescott MS, Shedden K, Misek DE, Thomas DG, Giordano TJ, Taylor JM, Kardia S, Yee J, Orringer MB, Hanash S, Beer DG. Proteomic analysis of cytokeratin isoforms uncovers association with survival in lung adenocarcinoma. Neoplasia 2002;4:440-8.
38. Chen G, Wang H, Gharib TG, Huang CC, Thomas DG, Shedden KA, Kuick R, Taylor JM, Kardia SL, Misek DE, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, Beer DG. Overexpression of oncoprotein 18 correlates with poor differentiation in lung adenocarcinomas. Mol Cell Proteomics 2003;2:107-16.
39. Liu Y, Chen Q, Zhang JT. Tumor suppressor gene 14-3-3sigma is down-regulated whereas the proto-oncogene translation elongation factor 1delta is up-regulated in non-small cell lung cancers as identified by proteomic profiling. J Proteome Res 2004;3:728-35.
40. Flores-Delgado G, Liu CW, Sposto R, Berndt N. A limited screen for protein interactions reveals new roles for protein phosphatase 1 in cell cycle control and apoptosis. J Proteome Res 2007;6:1165-75.
41. Ma PC, Tretiakova MS, Nallasura V, Jagadeeswaran R, Husain AN, Salgia R. Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumour invasion. Br J Cancer 2007;97:368-77.
42. Uno F, Sasaki J, Nishizaki M, Carboni G, Xu K, Atkinson EN, Kondo M, Minna JD, Roth JA, Ji L. Myristoylation of the fus1 protein is required for tumor suppression in human lung cancer cells. Cancer Res 2004;64:2969-76.
43. Beck HC, Nielsen EC, Matthiesen R, Jensen LH, Sehested M, Finn P, Grauslund M, Hansen AM, Jensen ON. Quantitative proteomic analysis of post-translational modifications of human histones. Mol Cell Proteomics 2006;5:1314-25.
44. Dennis JW, Granovsky M, Warren CE. Glycoprotein glycosylation and cancer progression. Biochim Biophys Acta 1999;1473:21-34.
45. Lowe JB. Glycosylation, immunity, and autoimmunity. Cell 2001;104:2364-9.
46. Kobata A, Amano J. Altered glycosylation of proteins produced by malignant cells, and application for the diagnosis and immunotherapy of tumours. Immunol Cell Biol 2005;83:429-39.
47. Patwa T, Zhao J, Anderson MA, Simeone DM, Lubman DM. Screening of glycosylation patterns in serum using natural glycoprotein microarrays and multi-lectin fluorescence detection. Anal Chem 2006;78:6411-21.
48. Hirabayashi J. Lectin-based structural glycomics: glycoproteomics and glycan profiling. Glycoconj J 2004;21:35-40.
49. Hart C, Schulenberg B, Steinberg TH, Leung WY, Patton WF. Detection of glycoproteins in polyacrylamide gels and on electroblots using Pro-Q Emerald 488 dye, a fluorescent periodate Schiff-base stain. Electrophoresis 2003;24:588-98.
50. Mechref Y, Novotny MV. Miniaturized separation techniques in glycomic investigations. J Chromatogr B Analyt Technol Biomed Life Sci 2006;841:65-78.
51. Mukherji M. Phosphoproteomics in analyzing signaling pathways. Expert Rev Proteomics 2005;2:117-28.
52. Zhang H, Zha X, Tan Y, Hornbeck PV, Mastrangelo AJ, Alessi DR, Polakiewicz RD, Comb MJ. Phosphoprotein analysis using antibodies broadly reactive against phosphorylated motifs. J Biol Chem 2002;277:39379-87.
53. Schmidt SR, Schweikart F, Anderson ME. Current methods for phosphoprotein isolation and enrichment. J Chromatogr B Analyt Technol Biomed Life Sci 2007;849:154-62.
54. Raggiaschi R, Gotta S, Terstappen GC. Phosphoproteome analysis. Biosci Rep 2005;25:33-44.
55. Goshe MB, Veenstra TD, Panisko EA, Conrads TP, Angell NH, Smith RD. Phosphoprotein isotope-coded affinity tags: application to the enrichment and identification of low-abundance phosphoproteins. Anal Chem 2002;74:607-16.
56. Ibarrola N, Kalume DE, Gronborg M, Iwahori A, Pandey A. A proteomic approach for quantitation of phosphorylation using stable isotope labeling in cell culture. Anal Chem 2003;75:6043-9.
57. Carr SA, Annan RS, Huddleston MJ. Mapping posttranslational modifications of proteins by MS-based selective detection: application to phosphoproteomics. Methods Enzymol 2005;405:82-115.
58. Julenius K, Molgaard A, Gupta R, Brunak S. Prediction, conservation analysis, and structural characterization of mammalian mucin-type O-glycosylation sites. Glycobiology 2005;15:153-64.
59. Gupta R, Brunak S. Prediction of glycosylation across the human proteome and the correlation to protein function. Pac Symp Biocomput 2002;310-22.
60. Blom N, Gammeltoft S, Brunak S. Sequence- and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol 1999;249:1351-62.
61. Diella F, Cameron S, Gemund C, Linding R, Via A, Kuster B, Sicheritz-Ponten T, Blom N, Gibson TJ. Phospho.ELM: a database of experimentally verified phosphorylation sites in eukaryotic proteins. BMC Bioinformatics 2004;5:79.
62. Lee TY, Huang HD, Hung JH, Huang HY, Yang YS, Wang TH. dbPTM: an information repository of protein post-translational modification. Nucleic Acids Res 2006;34:D622-7.